PIIND2024-07-012024-09-30 PIIND2024-07-012024-09-30 PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses02Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses03Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses04Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses05Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses06Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses07Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses08Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses09Member PIIND2024-07-012024-09-30in-bse-fin:OneOperatingExpenses10Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses02Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses03Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses04Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses05Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses06Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses07Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses08Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses09Member PIIND2024-07-012024-09-30in-bse-fin:FourOperatingExpenses10Member PIIND2024-09-30 PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue01Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue02Member PIIND2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue01Member PIIND2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue02Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults01Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults02Member PIIND2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults01Member PIIND2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults02Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets01Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets02Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities01Member PIIND2024-09-30in-bse-fin:OneReportableSegmentLiabilities01Member PIIND2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities02Member PIIND2024-09-30in-bse-fin:OneReportableSegmentLiabilities02Member PIIND2024-07-012024-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2024-07-012024-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2024-07-012024-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2024-07-012024-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member PIIND2024-07-012024-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2024-07-012024-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 523642 PIIND NOTLISTED PI Industries Limited Equity 2024-04-01 2025-03-31 2024-11-13 2024-10-29 INR Millions Half yearly 14:00:00 17:00:00 2024-11-13 2024-11-13 true Cash Flow Indirect Not applicable Multi segment 2024-07-01 2024-09-30 Unaudited Consolidated 22210000000.00 1222000000.00 23432000000.00 9158000000.00 811000000.00 745000000.00 1956000000.00 85000000.00 798000000.00 3258000000.00 16811000000.00 6621000000.00 0.00 6621000000.00 1374000000.00 172000000.00 1546000000.00 0.00 5075000000.00 0.00 0.00 0.00 7000000.00 5082000000.00 -89000000.00 4993000000.00 4993000000.00 0.00 4993000000.00 0.00 152000000.00 1 33.51 33.50 0.00 0.00 33.51 33.50 Notes: 1 The above Consolidated financial results were reviewed and recommended by the Audit Committee of the Company and approved by the Board of Directors at their meeting held on November 13, 2024. 2 Consolidated Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3 The Consolidated financial results include the results of the following entitles namely, Parent Company - Pl Industries Limited; Subsidiaries (including step down subsidiaries): (a) PILL Finance and Investments Limited (b) Pl Life Science Research Limited (c) Pl Japan Co. Limited (d) Jivagro Limited (e) Pl Bioferma Private Limited (f) Pl Fermachem Private Limited (g) Pl Health Sciences Limited (h) Pl Health Sciences USA, LLC (i) Pl Health Sciences Netherlands BV (j) Archimica S.p.A Italy (k) Pl Industries Management Consultancies L.L.C Dubai (I) Plant Health Care limited (m) Plant Health Care, Inc, Nevada (n) Plant Health Care, Inc, Pennsylvania (o) Plant Health Care de Mexico S. de R.L. de C.V. (p) Plant Health Care (UK) Limited (q) Plant Health Care Espaiia (r) Plant Health Care lnsumos Agricolas LTDA (s) VAMTech, LLC ;Controlled trust - Pl ESOP Trust; Joint Venture - (a) Pl Kumiai Private Limited (b) Pl Flowtech B.V.; Associate - Solinnos Agro Sciences Private Limited. 4 Statement of Consolidated Cash Flows is attached in Annexure I. 5 The Company raised Rs. 20,000 Mn during the quarter ended September 30, 2020 through Qualified Institutional Placement (QIP) of equity shares. Out of the funds received of Rs.19,750 Mn (net of expense of Rs. 250 Mn), the Company invested Rs. 14,789 Mn in its subsidiaries. Balance funds Rs. 4,961 Mn received pursuant to QIP remain Invested in liquid and other debt mutual funds. 6 During the quarter, the Company ( Pl Industries Ltd. ) has acquired the entire share capital of Plant Health Care Pie, a England and Wales Incorporated Company through Its wholly owned subsidiary, Pl Industries Management Consultancies L.L.C. , Dubai. This acquisition is effective from August 20, 2024 pursuant to a court sanctioned scheme of arrangement. This transaction has been accounted for in accordance with the acquisition method specified in Ind AS 103 Business Combination . Out of the total purchase consideration of Rs. 3,639 Mn, Rs. 1,696 Mn, representing excess of the provisional fair value of the net assets acquired, has been recognised as provisional goodwill, subject to finalisation. 7 Segment information as per Ind AS 108 Operating Segments is as per Annexure II. Multi segment 2024-04-01 2024-09-30 Unaudited Consolidated 42899000000.00 1949000000.00 44848000000.00 17641000000.00 1093000000.00 1957000000.00 3957000000.00 168000000.00 1632000000.00 6137000000.00 32585000000.00 12263000000.00 0.00 12263000000.00 2384000000.00 337000000.00 2721000000.00 0.00 9542000000.00 0.00 0.00 0.00 28000000.00 9570000000.00 -33000000.00 9537000000.00 9537000000.00 0.00 9537000000.00 0.00 152000000.00 1 63.10 63.09 0.00 0.00 63.10 63.09 Advertisement & Sales Promotion 207000000.00 Environment & Pollution Control Expenses 300000000.00 Freight & Cartage 152000000.00 Laboratory & Testing Charges 170000000.00 Legal & professional fees 207000000.00 Net Impairment losses on Financial Assets 252000000.00 Others 750000000.00 Power, Fuel & Water 712000000.00 Repairs & Maintenance 288000000.00 Travelling and Conveyance 220000000.00 Advertisement & Sales Promotion 353000000.00 Environment & Pollution Control Expenses 681000000.00 Freight & Cartage 278000000.00 Laboratory & Testing Charges 298000000.00 Legal & professional fees 589000000.00 Net Impairment losses on Financial Assets 291000000.00 Others 1305000000.00 Power, Fuel & Water 1327000000.00 Repairs & Maintenance 570000000.00 Travelling and Conveyance 445000000.00 0.00 29290000000.00 4714000000.00 0.00 5333000000.00 3900000000.00 1352000000.00 0.00 364000000.00 1332000000.00 0.00 0.00 254000000.00 1586000000.00 200000000.00 823000000.00 47562000000.00 11648000000.00 10635000000.00 18040000000.00 8136000000.00 20304000000.00 52000000.00 273000000.00 57440000000.00 0.00 3301000000.00 72389000000.00 0.00 0.00 119951000000.00 152000000.00 95302000000.00 95454000000.00 95454000000.00 537000000.00 0.00 2197000000.00 2734000000.00 477000000.00 344000000.00 0.00 0.00 3555000000.00 536000000.00 13342000000.00 4968000000.00 18846000000.00 1044000000.00 294000000.00 758000000.00 0.00 20942000000.00 0.00 0.00 24497000000.00 119951000000.00 Agro Chemicals 21799000000.00 Pharma 411000000.00 Agro Chemicals 42238000000.00 Pharma 664000000.00 22210000000.00 42902000000.00 0.00 3000000.00 22210000000.00 42899000000.00 Agro Chemicals 7179000000.00 Pharma -551000000.00 Agro Chemicals 13559000000.00 Pharma -1268000000.00 6628000000.00 12291000000.00 0.00 0.00 0.00 0.00 6628000000.00 12291000000.00 Agro Chemicals 107061000000.00 Pharma 12890000000.00 119951000000.00 0.00 119951000000.00 Agro Chemicals 20593000000.00 Pharma 3904000000.00 24497000000.00 0.00 24497000000.00 168000000.00 1600000000.00 -6826000000.00 0.00 -10000000.00 -1000000.00 22000000.00 -98000000.00 0.00 1654000000.00 0.00 54000000.00 0.00 1632000000.00 291000000.00 0.00 113000000.00 748000000.00 130000000.00 -186000000.00 0.00 1083000000.00 20000000.00 -302000000.00 0.00 18000000.00 28000000.00 -390000000.00 -28000000.00 -2446000000.00 9817000000.00 0.00 0.00 0.00 1811000000.00 0.00 8006000000.00 0.00 3565000000.00 0.00 0.00 0.00 0.00 0.00 0.00 89000000.00 3840000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1083000000.00 0.00 -642000000.00 0.00 -6875000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 236000000.00 0.00 107000000.00 1365000000.00 168000000.00 0.00 0.00 -1876000000.00 -745000000.00 16000000.00 -729000000.00 8865000000.00 8136000000.00 Remeasurements gain/(loss) on cash flow hedges -24000000.00 Remeasurements gain/(loss) on cash flow hedges -47000000.00 -24000000.00 -47000000.00 -9000000.00 -17000000.00 Effective portion of gain/(loss) on cashflow hedges -353000000.00 Exchange difference on translation of foreign operations 158000000.00 Effective portion of gain/(loss) on cashflow hedges -223000000.00 Exchange difference on translation of foreign operations 136000000.00 -195000000.00 -87000000.00 -121000000.00 -84000000.00